Cargando...
NasdaqGS: INCY
Operaciones reportadas en formularios SEC Form 4. Las compras se muestran en verde y las ventas en rojo.
| Fecha | Insider | Cargo | Operación | Acciones | Precio | Valor total |
|---|---|---|---|---|---|---|
| 08/05/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Exercise | 15.000 | $84,53 | $1,3M |
| 08/05/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Exercise | 15.000 | $84,53 | $1,3M |
| 08/05/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Unknown | 15.000 | $0,00 | $0 |
| 08/05/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Unknown | 15.000 | $0,00 | $0 |
| 04/05/2026 | Suketu Upadhyay | EVP & Chief Financial Officer | Unknown | 13.171 | $0,00 | $0 |
| 04/05/2026 | Suketu Upadhyay | EVP & Chief Financial Officer | Award | 26.343 | $0,00 | $0 |
| 04/05/2026 | Suketu Upadhyay | EVP & Chief Financial Officer | Unknown | 38.429 | $0,00 | $0 |
| 17/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Exercise | 6.077 | $64,25 | $390,4K |
| 17/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Unknown | 12.590 | $0,00 | $0 |
| 17/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Unknown | 6.077 | $0,00 | $0 |
| 17/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Exercise | 12.590 | $71,93 | $905,6K |
| 17/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Sale | 18.667 | $96,50 | $1,8M |
| 15/04/2026 | Steven H Stein | CMO & Head of Late-Stage Dev. | Award | 39.049 | $0,00 | $0 |
| 15/04/2026 | Pablo J Cagnoni | President, Global Head of R&D | Award | 27.892 | $0,00 | $0 |
| 15/04/2026 | William Meury | Chief Executive Officer | Exercise | 125.000 | $0,00 | $0 |
| 31/03/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Award | 421 | $0,00 | $0 |
| 31/03/2026 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Award | 421 | $0,00 | $0 |
| 31/03/2026 | Paul J Clancy | Director | Award | 265 | $94,12 | $24,9K |
| 31/03/2026 | Edmund Harrigan | Director | Award | 269 | $94,12 | $25,3K |
| 25/03/2026 | Matteo Trotta | EVP, GM, Dermatology US | Tax Withholding | 537 | $92,23 | $49,5K |
| 17/03/2026 | Pablo J Cagnoni | President, R&D | Unknown | 7.166 | $0,00 | $0 |
| 17/03/2026 | Pablo J Cagnoni | President, R&D | Exercise | 7.166 | $61,18 | $438,4K |
| 17/03/2026 | Pablo J Cagnoni | President, R&D | Unknown | 11.501 | $0,00 | $0 |
| 17/03/2026 | Pablo J Cagnoni | President, R&D | Sale | 18.667 | $94,24 | $1,8M |
| 17/03/2026 | Pablo J Cagnoni | President, R&D | Exercise | 11.501 | $64,25 | $738,9K |
| 19/02/2026 | Pablo J Cagnoni | President, R&D | Sale | 18.668 | $100,91 | $1,9M |
| 19/02/2026 | Pablo J Cagnoni | President, R&D | Unknown | 13.093 | $0,00 | $0 |
| 19/02/2026 | Pablo J Cagnoni | President, R&D | Exercise | 5.575 | $61,18 | $341,1K |
| 19/02/2026 | Pablo J Cagnoni | President, R&D | Exercise | 13.093 | $61,76 | $808,6K |
| 19/02/2026 | Pablo J Cagnoni | President, R&D | Unknown | 5.575 | $0,00 | $0 |
| 02/02/2026 | Lee Heeson | EVP, Head of Incyte Intl | Tax Withholding | 111 | $102,67 | $11,4K |
| 02/02/2026 | Michael James Morrissey | EVP, Head of Tech. Operations | Tax Withholding | 185 | $102,67 | $19,0K |
| 20/01/2026 | Michael James Morrissey | EVP, Head of Tech. Operations | Tax Withholding | 429 | $102,62 | $44,0K |
| 16/01/2026 | Lee Heeson | EVP, Head of Incyte Intl | Award | 8.911 | $0,00 | $0 |
| 16/01/2026 | Michael James Morrissey | EVP, Head of Tech. Operations | Award | 7.426 | $0,00 | $0 |
| 16/01/2026 | Pablo J Cagnoni | President, R&D | Unknown | 28.475 | $0,00 | $0 |
| 16/01/2026 | Patrick A Mayes | EVP & Chief Scientific Officer | Unknown | 4.218 | $0,00 | $0 |
| 16/01/2026 | Thomas Tray | Principal Accounting Officer | Unknown | 2.425 | $0,00 | $0 |
| 16/01/2026 | Matteo Trotta | EVP, GM, Dermatology US | Unknown | 8.542 | $0,00 | $0 |
| 16/01/2026 | Mohamed Khairie Issa | EVP, Head of US Oncology | Unknown | 14.237 | $0,00 | $0 |
| 16/01/2026 | Steven H Stein | EVP & Chief Medical Officer | Unknown | 19.932 | $0,00 | $0 |
| 07/01/2026 | Mohamed Khairie Issa | EVP, Head of US Oncology | Sale | 10.856 | $109,07 | $1,2M |
| 06/01/2026 | Mohamed Khairie Issa | EVP, Head of US Oncology | Tax Withholding | 8.264 | $106,66 | $881,4K |
| 05/01/2026 | Steven H Stein | EVP & Chief Medical Officer | Sale | 15.634 | $101,70 | $1,6M |
| 31/12/2025 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Award | 328 | $0,00 | $0 |
| 31/12/2025 | BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / Felix Baker / Julian Baker | Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner/ Director, 10% Owner | Award | 328 | $0,00 | $0 |
| 31/12/2025 | Michael James Morrissey | EVP, Head of Tech. Operations | Tax Withholding | 254 | $98,77 | $25,1K |
| 31/12/2025 | Steven H Stein | EVP & Chief Medical Officer | Tax Withholding | 13.292 | $98,77 | $1,3M |
| 31/12/2025 | Edmund Harrigan | Director | Award | 245 | $98,77 | $24,2K |
| 31/12/2025 | Paul J Clancy | Director | Award | 241 | $98,77 | $23,8K |
Principales tenedores institucionales por valor de la posición.
| Holder | Tipo | % del flotante | Acciones | Valor | Reportado |
|---|---|---|---|---|---|
| Baker Bros. Advisors, LP | Institución | 0,15% | 30.743.991 | $3,0B | 31/12/2025 |
| Vanguard Group Inc | Institución | 0,10% | 19.911.434 | $2,0B | 31/12/2025 |
| Blackrock Inc. | Institución | 0,09% | 18.327.923 | $1,8B | 31/12/2025 |
| Dodge & Cox Inc. | Institución | 0,07% | 13.261.742 | $1,3B | 31/12/2025 |
| State Street Corporation | Institución | 0,05% | 9.656.403 | $951,7M | 31/12/2025 |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | Fondo | 0,05% | 8.987.414 | $885,8M | 31/12/2025 |
| AQR Capital Management, LLC | Institución | 0,03% | 6.720.024 | $662,3M | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | Fondo | 0,03% | 5.236.865 | $516,1M | 31/12/2025 |
| Geode Capital Management, LLC | Institución | 0,03% | 4.993.012 | $492,1M | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | Fondo | 0,02% | 4.159.082 | $409,9M | 31/12/2025 |